| Xiromed SA - Sitagliptin-Metformin Xiromed 50 mg/1000 mg, Filmtabletten | | 68571 | | 03 | | Sitagliptin-Metformin Xiromed 50 mg/1000 mg | | Filmtabletten | | A10BD07 | | Metformine et Sitagliptine | | 09.06.2022 | | |
| | Composition | | sitagliptinum 50 mg ut sitagliptini hydrochloridum monohydricum, metformini hydrochloridum 1000 mg, cellulosum microcristallinum, povidonum K 29-32, natrii laurilsulfas, natrii stearylis fumaras, Überzug: poly(alcohol vinylicus), E 171, macrogolum 3350, talcum, E 172 (rubrum), E 172 (nigrum), pro compresso obducto corresp. natrium 2.32 mg. | | Packungsbestandteile | | Comprimés filmés | | | | Principe actif | Concentr. |
|---|
| Metformine Hydrochloride | 1000 mg | | Sitagliptine | 50 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Nigrum) | | | | (Rubrum) | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Macrogol | 3350 | | | Natrii Laurilsulfas | | | | Natrii Stearylis Fumaras | | | | Poly(Alcohol Vinylicus) | | Überzug | | Povidonum K | 29-32 | | | Pro Compresso Obducto | | | | Talcum | | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 017 | 56 | DDP | DDP | B | | Oui | | 018 | 196 | DDP | DDP | B | | Oui |
|
|
